Lamis Al Harby, MD
Contact information
LOCATION
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
FELLOWSHIP
Moorfields Eye Hospital
RESIDENCY
Ludwig Maximilian University of Munich
MEDICAL SCHOOL
Faculty of Medicine- Ovidius University of Constanta
Current Positions
Ophthalmic Oncologist
PhD Candidate
Biography
ACADEMIC APPOINTMENTS:
Doctor of Philosophy Researcher/Candidate, Ocular Oncology
Institute of Ophthalmology
University College London (UCL)
London, United Kingdom
September 2018 - Expected date of completion: 2022
MEDICAL TRAINING:
Ocular Oncology Observership,November 2017- December 2017.
Wills Eye Hospital
Philadelphia, Pennsylvania. USA
Ocular Oncology Fellowship, March 2014 – August 2018
Moorfields Eye Hospital and St. Bartholomew Hospital
London, England, United Kingdom
Ophthalmology Residency, 2005 – 2012
Ludwig-Maximilians Universität München
Munich, Germany
EDUCATION:
Doctor of Medicine, 1994- 2000.
Universitatea OVIDIUS din Constanta
Romania
SOCIETY MEMBERSHIP:
2017 - Present Member of Women in Ocular Oncology Group (WOO)
2017 - Present Member of Young Ocular Oncologists (YOO)
2014 - Present Member of the Royal College of Ophthalmologists (RCOph)
2014 - Present International Society of Ocular Oncology (ISOO)
2014 - Present General Medical Council (GMC)
2005 - 2012 Deutsche Ophthalmologische Gesellschaft (DOG)
2020- Present Member of The International Society of Paediatric Oncology (SIOP)
LOCATION
- Ministry of Health - UAE,
Abudhabi, 1234
Map and directions »
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
FELLOWSHIP
Moorfields Eye Hospital
RESIDENCY
Ludwig Maximilian University of Munich
MEDICAL SCHOOL
Faculty of Medicine- Ovidius University of Constanta
Current Positions
Ophthalmic Oncologist
PhD Candidate
Biography
ACADEMIC APPOINTMENTS:
Doctor of Philosophy Researcher/Candidate, Ocular Oncology
Institute of Ophthalmology
University College London (UCL)
London, United Kingdom
September 2018 - Expected date of completion: 2022
MEDICAL TRAINING:
Ocular Oncology Observership,November 2017- December 2017.
Wills Eye Hospital
Philadelphia, Pennsylvania. USA
Ocular Oncology Fellowship, March 2014 – August 2018
Moorfields Eye Hospital and St. Bartholomew Hospital
London, England, United Kingdom
Ophthalmology Residency, 2005 – 2012
Ludwig-Maximilians Universität München
Munich, Germany
EDUCATION:
Doctor of Medicine, 1994- 2000.
Universitatea OVIDIUS din Constanta
Romania
SOCIETY MEMBERSHIP:
2017 - Present Member of Women in Ocular Oncology Group (WOO)
2017 - Present Member of Young Ocular Oncologists (YOO)
2014 - Present Member of the Royal College of Ophthalmologists (RCOph)
2014 - Present International Society of Ocular Oncology (ISOO)
2014 - Present General Medical Council (GMC)
2005 - 2012 Deutsche Ophthalmologische Gesellschaft (DOG)
2020- Present Member of The International Society of Paediatric Oncology (SIOP)
Selected publications
- The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?
MDPI/Cancers.Volume12.Issue5.21 May 2020 - Global Retinoblastoma Presentation and Analysis by National Income Level
JAMA Oncology . 2020 Feb 27;6(5):1-12 - Primary Photodynamic Therapy With Verteporfin for Pigmented Posterior Pole cT1a Choroidal Melanoma: A 3-year Retrospective Analysis
The British journal of ophthalmology . 2018 Dec;102(12):1705-1710 - Implantation Pearl Cyst After Uncomplicated Clear Cornea Phacoemulsification Mimicking an Iris Tumour
Canadian journal of Ophthalmology. Volume 53,ISSUE 1,E10-E13,February 01, 2018 - Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma
American journal of ophthalmology. 2017 Sep;181:97-105 - Primary Photodynamic Therapy With Verteporfin for Small Pigmented Posterior Pole Choroidal Melanoma
Eye. Volume 31, pages519–528(2017) - Rare Tumors: An Eye on the Future
Future Oncology. (2015) 11(19), 2641–2644 - Intravitreal Bevacizumab Monotherapy for Choroidal Neovascularisation Secondary to Choroidal Osteoma
Eye.Volume 30, pages843–849(2016) - Detecting Progression of Melanocytic Choroidal Tumors by Sequential Imaging: Is Ultrasonography Necessary?
MDPI/Cancers.Volume12.Issue7.10 July 2020 - Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries
Paediatric Blood & Cancer 6th August 2020 - Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment
The British journal of ophthalmology. 9th Oct 2020